Oncology Clinical Trials
Find clinical trials for oncology. Search for oncology clinical trials in different cities and states across the United States.
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate CancerPilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT04808427
Conditions
Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
TULSA-PRO
Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell TransplantExercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant
Sponsor:
M.D. Anderson Cancer Center
Location:
Code:
NCT04678427
Conditions
Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm
Eligibility Criteria
Sex: All
Age: 6 - 29
Healthy Volunteers: Not accepted
Interventions
6 Minute Walk Functional Test
Behavioral Intervention
Survey Administration
Timed Get Up and Go Test
Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing SurgeryDoxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery
Sponsor:
Dr. Susan Love Research Foundation
Location:
Code:
NCT00671476
Conditions
Breast Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
pegylated liposomal doxorubicin hydrochloride
DNA methylation analysis
TdT-mediated dUTP nick end labeling assay
fluorescence in situ hybridization
loss of heterozygosity analysis
Diagnosing and Treating Low Blood Sugar LevelsDiagnosing and Treating Low Blood Sugar Levels
Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Location:
Code:
NCT00001276
Conditions
Hypoglycemia
Insulinoma
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Lymphatic Anomalies Registry for the Assessment of Outcome DataLymphatic Anomalies Registry for the Assessment of Outcome Data
Sponsor:
Boston Children's Hospital
Location:
Code:
NCT02399527
Conditions
Lymphatic Malformation
Generalized Lymphatic Anomaly (GLA)
Central Conducting Lymphatic Anomaly
CLOVES Syndrome
Gorham-Stout Disease ("Disappearing Bone Disease")
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Study to Allow Patients Previously Participating in a Novartis Sponsored Trial to Continue Receiving Capmatinib Treatment as Single Agent or in Combination With Other Treatments or the Combination Treatment AloneStudy to Allow Patients Previously Participating in a Novartis Sponsored Trial to Continue Receiving Capmatinib Treatment as Single Agent or in Combination With Other Treatments or the Combination Treatment Alone
Sponsor:
Novartis Pharmaceuticals
Location:
Code:
NCT03040973
Conditions
Advanced Solid Tumors Which Are cMET-dependent
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Capmatinib
Nazartinib
Gefitinib
Osimertinib
Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast CancerComparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer
Sponsor:
City of Hope Medical Center
Location:
Code:
NCT05340673
Conditions
Breast Ductal Carcinoma In Situ
Invasive Breast Carcinoma
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Agent Affecting Integumentary System
Petrolatum-Mineral Oil-Lanolin-Ceresin Ointment
Quality-of-Life Assessment
Questionnaire Administration
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin LymphomaImmune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
Sponsor:
AIDS Malignancy Consortium
Location:
Code:
NCT05077527
Conditions
AIDS-Related Diffuse Large B-cell Lymphoma
AIDS-Related Non-Hodgkin Lymphoma
HIV Infection
Recurrent Diffuse Large B-Cell Lymphoma
Recurrent Grade 3b Follicular Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Axicabtagene Ciloleucel
Cyclophosphamide
Fludarabine
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Sponsor:
M.D. Anderson Cancer Center
Location:
Code:
NCT01515527
Conditions
Leukemia
Eligibility Criteria
Sex: All
Age: 60+
Healthy Volunteers: Not accepted
Interventions
Cladribine
Cytarabine
Decitabine
JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid TumorsJAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors
Sponsor:
Jacobio Pharmaceuticals Co., Ltd.
Location:
Code:
NCT04720976
Conditions
Solid Tumor
NSCLC
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
JAB-3312
Binimetinib
Pembrolizumab
Sotorasib
Osimertinib
What are clinical trials for cancer?
Clinical trials for cancer are research studies that aim to evaluate new ways to prevent, detect, or treat cancer. These trials test the safety and effectiveness of new treatments, procedures, or drugs in comparison to current standards. They may also show which medical approaches work best for certain types of cancer or groups of people.
The importance of clinical trials in cancer research
Cancer clinical trials are crucial for developing new methods to fight cancer, improving patient outcomes, and may offer participants access to cutting-edge therapies before they are widely available.
Types of cancer clinical trials
Oncology clinical trials are designed to address different aspects of cancer care, including how to treat cancer, prevent it, find it early, or improve the quality of life for people with cancer. The main types are:
Treatment trials
Treatment trials test new treatments or new combinations of treatments, such as new drugs, new surgical techniques, or new radiation therapies. The goal is to find more effective ways to treat cancer with fewer side effects.
Prevention trials
Prevention trials look for better ways to prevent cancer in people who have never had cancer or to prevent cancer from returning. These trials may include studying medicines, vaccines, vitamins, minerals, or lifestyle changes.
Screening trials
Screening trials test the best way to detect cancer, especially in its early stages. These trials study new examinations or tests that might be more effective, safer, or less invasive than the current standard screening methods.
Quality of life trials for cancer survivors
Quality of life trials (or supportive care trials) explore ways to improve comfort and the quality of life for individuals with terminal types of cancer and cancer survivors. They may study issues such as managing side effects of treatment, physical, psychological, and social side effects of cancer and its treatment.
Who can participate in oncology trials?
Eligibility for oncology trials varies widely depending on the study's objectives. Factors can include the type and stage of cancer, previous treatment history, age, gender, overall health, and other medical conditions. Researchers conducting the trial set specific criteria for each trial to ensure accurate and reliable results and to keep participants safe.
What to expect when participating in a cancer clinical trial
Participating in a cancer clinical trial often involves detailed screenings, regular health check-ups, and a structured treatment plan. Participants may receive the new treatment being tested, a standard treatment for their cancer, or a placebo, depending on the trial's design. Throughout the trial, researchers will monitor the health of participants and the effectiveness and side effects of the treatment.
Benefits and risks of participating in cancer clinical trials
Participating in cancer clinical trials offers potential benefits, including access to new treatments before they are widely available and contributing to medical research that may benefit others in the future. They also receive close monitoring from a dedicated healthcare team.
However, there are also risks, such as the new treatments under study are not always better than the standard care, and there may be unexpected side effects. Participation may also require more of their time and attention, including trips to the study site, more treatments, hospital stays, or complex dosage requirements.
Unsure about participating in clinical trials? Dive into our comprehensive guide to learn about the process, benefits, and potential impact of your involvement. Get the facts you need to make an informed decision today!
How to enroll in a clinical trial for cancer
Enrolling in a cancer clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify Your Trial: Use our intuitive search bar or filter options to locate clinical trials specific to your cancer type. This first step simplifies the process of finding relevant research studies tailored to your needs.
- Select Your Preferred Location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore Study Details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the Health Profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the Application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.